Risk factors associated with prolonged treatment courses of chronic hepatitis E.
A subset of patients exhibits persistent infection despite therapy, underscoring the need for improved antiviral strategies and individualized management.
We have 2 of 21 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
A subset of patients exhibits persistent infection despite therapy, underscoring the need for improved antiviral strategies and individualized management.
Findings identify CD96 as a marker of a phenotypically distinct checkpoint-associated HCV-specific CD8+ T-cell subset featuring memory-associated rather than terminally exhausted states.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.